Back to Search
DAVID CRANDALL, M.D.
M.D.
Obstetrics & Gynecology Physician
NPI: 1033195383IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
036-078801(IL)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE
Class of 1984
Research & Publications (20)
Modulation of adipose tissue development by pharmacological inhibition of PAI-1.
PMID 16825598·Arterioscler Thromb Vasc Biol·2006
7-preclinical
Characterization and comparative evaluation of a structurally unique PAI-1 inhibitor exhibiting oral in-vivo efficacy.
PMID 15304050·J Thromb Haemost·2004
7-preclinical
WAY-140312 reduces plasma PAI-1 while maintaining normal platelet aggregation.
PMID 14623266·Biochem Biophys Res Commun·2003
7-preclinical
Release of PAI-1 by human preadipocytes and adipocytes independent of insulin and IGF-1.
PMID 11162462·Biochem Biophys Res Commun·2000
8-other
Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury.
PMID 19480973·Int J Radiat Oncol Biol Phys·2009
7-preclinical
The relationship between super users' attitudes and employee experiences with clinical information systems.
PMID 19047764·Med Care Res Rev·2009
8-other
The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
PMID 19192472·J Clin Psychiatry·2009
4-observational
An exploratory study measuring verbal order content and context.
PMID 19467997·Qual Saf Health Care·2009
8-other
Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis.
PMID 18624980·J Thromb Haemost·2008
7-preclinical
The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: a pooled analysis of data from the pivotal trials.
PMID 18790605·Schizophr Res·2008
4-observational
Biomechanical modelling of a direct vertebral translation instrumentation system: preliminary results.
PMID 18810013·Stud Health Technol Inform·2008
8-other
Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis.
PMID 18024786·J Pharmacol Exp Ther·2008
4-observational
Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade.
PMID 18559859·Proc Natl Acad Sci U S A·2008
7-preclinical
Dose-dependent thrombus resolution due to oral plaminogen activator inhibitor (PAI)-1 inhibition with tiplaxtinin in a rat stenosis model of venous thrombosis.
PMID 18392333·Thromb Haemost·2008
7-preclinical
Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine.
PMID 18973991·Schizophr Res·2008
4-observational
p38 mitogen-activated protein kinase-dependent tumor necrosis factor-alpha-converting enzyme is important for liver injury in hepatotoxic interaction between lipopolysaccharide and ranitidine.
PMID 18390808·J Pharmacol Exp Ther·2008
4-observational
Redesigning care delivery through health IT implementation. Exploring Trinity Health's IT model.
PMID 19195280·J Healthc Inf Manag·2007
8-other
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline.
PMID 17915976·J Clin Psychiatry·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 22N285 PEPPER RD, SUITE #111
LAKE BARRINGTON, IL 60010 - Phone
- (847) 382-7330
Quick Facts
- NPI
- 1033195383
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile